Navigation Links
Senior Research Analyst Richard Evans Joins AVOS Life Sciences
Date:9/12/2007

MORRISVILLE, N.C., Sept. 12 /PRNewswire/ -- AVOS Life Sciences announced today that Richard Evans has joined AVOS as Vice President. His primary responsibility will be providing advisory services to companies in the prescription drug and biotech areas as well as selected investment assignments in capital markets. As an Institutional Investor (II) rated drug analyst, he will also have responsibility for AVOS' emerging portfolio of research products in the capital markets area.

"Richard brings us a senior level perspective on the drug industry," said Neil MacAllister, president of AVOS Life Sciences. "His background in capital markets complements our team and helps position AVOS as one of the strongest research and analysis firms in the pharmaceutical industry."

Mr. Evans has received several national awards from publications such as Bloomberg Markets magazine. He has been profiled in Barron's and Street.com. Richard has also provided financial commentary for The Wall Street Journal, The New York Times, CNBC, CNN, and NPR.

Mr. Evans earned a master's degree in Public and Private Management from Yale University. He is also a Doctor of Veterinary Medicine, having received his degree from North Carolina State University.

"One of AVOS' strengths," continued MacAllister, "is our first hand experience gained through extensive consulting engagements delivering strategic, operational and financial insight to healthcare and drug companies. Richard's expertise in analyzing financial market conditions will greatly add to AVOS' ability to deliver actionable recommendations to our clients by providing them with a full understanding of capital market reaction."

AVOS Life Sciences, LLC is a healthcare consulting and research firm located in Morrisville, North Carolina, and New York, New York. The company helps clients understand the rapidly evolving pharmaceutical, biotechnology, medical device and diagnostic market segments, thereby assisting with strategic business development and investment decisions. AVOS' analytical tools are structured to assist with real-time decision-making in a dynamic environment.

AVOS' proprietary approach includes knowledge obtained through coverage of leading industry events, access to internal and external healthcare databases and the analysis and perceptive commentary of a network of experts such as leading pharma executives, global regulatory specialists, manufacturing and reimbursement consultants, and a team of analytical scientists.

For more information on Richard Evans joining AVOS, please contact kgriffin@avoslifesciences.com

http://www.avoslifesciences.com


'/>"/>
SOURCE AVOS Life Sciences, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. SecurePipe appoints two senior execs
2. Third Wave announces two senior management appointments
3. Senior Wisconsin stem-cell researcher leaves for Connecticut
4. Sonic Foundry names new senior vice president
5. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
6. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
7. Control Your siRNA Research
8. Getting Started with MicroRNA Research
9. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
10. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
11. Research Organics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... Genome Diagnostics Inc. (PGDx) today announced that it has three ... (AACR) Annual Meeting 2017, being held April 1-5, 2017, in ... that five scientists associated with PGDx—two co-founders and three scientific ... Science Award. ... Doug Ward , CEO of Personal Genome Diagnostics, ...
(Date:3/29/2017)... , March 29, 2017 QIAGEN N.V. (NASDAQ: ... announced the U.S. launch of its ipsogen ® JAK2 RGQ ... Food and Drug Administration as a qualitative in vitro diagnostic test for the ... blood.* ... is processed on QIAGEN,s Rotor-Gene ® Q MDx system, which is a ...
(Date:3/29/2017)... ... March 29, 2017 , ... (March 29, 2017) — ... approved as an active member of the Mexican Direct Selling Association A.C. ... consumers in relationship marketing. This professional organization fosters loyal and fair competition among ...
(Date:3/29/2017)... CA (PRWEB) , ... March 29, 2017 , ... ... cutting edge instrumentation for cell-based assays, disperses a quarterly travel award to noteworthy ... Today the company announced that its new round of awards are being ...
Breaking Biology Technology:
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... , March 2, 2017 Summary ... understand Perrigo and its partnering interests and activities since 2010. ... Read ... Deals and Alliance since 2010 report provides an in-depth insight ... life sciences companies. On demand company reports are ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
Breaking Biology News(10 mins):